Answers are grounded in this paper and cite their sources.
An ambient, surfactant-based synthetic means was used to prepare ultrathin binary ( d ∼ 2 nm) Pd–Ni nanowires, which were subsequently purified using a novel butylamine-based surfactant-exchange process coupled with an electrochemical CO adsorption and stripping treatment to expose active surface sites. We were able to systematically vary the chemical composition of as-prepared Pd–Ni nanowires from pure elemental Pd to Pd 0.50 Ni 0.50 (atomic ratio), as verified using EDS analysis. The overall morphology of samples possessing >60 atom % Pd consisted of individual, discrete one-dimensional nanowires. The electrocatalytic performances of elemental Pd, Pd 0.90 Ni 0.10, Pd 0.83 Ni 0.17, and Pd 0.75 Ni 0.25 nanowires in particular were examined. Our results highlight a “volcano”-type relationship between chemical composition and corresponding ORR activities with Pd 0.90 Ni 0.10, yielding the highest activity (i.e., 1.96 mA/cm 2 at 0.8 V) among all nanowires tested. Moreover, the Pd 0.90 Ni 0.10 sample exhibited outstanding methanol tolerance ability. In essence, there was only a relatively minimal 15% loss in the specific activity in the presence of 4 mM methanol, which was significantly better than analogous data on Pt nanoparticles and Pt nanowires. In addition, we also studied ultrathin, core–shell Pt∼Pd 0.90 Ni 0.10 nanowires, which exhibited a specific activity of 0.62 mA/cm 2 and a corresponding mass activity of 1.44 A/mg Pt at 0.9 V. Moreover, our as-prepared core–shell electrocatalysts maintained excellent electrochemical durability. We postulate that one-dimensional Pd–Ni nanostructures represent a particularly promising platform for designing ORR catalysts with high performance.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: